VIENNA — A new, open-access simulator gives providers the tools to show natural progression of non-alcoholic fatty liver disease to their patients using personalized factors, according to an expert at the International Liver Congress.
“We developed an open-access interactive tool for patients and providers that can help them understand such long-term risks. Also, the other objective is to increase awareness of NASH and its consequences in patients,” Jagpreet Chhatwal, PhD, from Massachusetts General Hospital, said during his presentation. “We wanted to create something

Source link